Pris J - Search Results

1

Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.

Attal M, Huguet F, Schlaifer D, Payen C, Lassoued S, Laroche M, Rossi JF, Fournie B, Mazieres B, Pris J, et al. Attal M, et al. Among authors: pris j. Bone Marrow Transplant. 1991 Aug;8(2):125-8. Bone Marrow Transplant. 1991. PMID: 1933053

2

Intensive combined therapy for previously untreated aggressive myeloma.

Attal M, Huguet F, Schlaifer D, Payen C, Laroche M, Fournie B, Mazieres B, Pris J, Laurent G. Attal M, et al. Among authors: pris j. Blood. 1992 Mar 1;79(5):1130-6. Blood. 1992. PMID: 1536941 Free article. Clinical Trial.

3

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation.

Schlaifer D, Attal M, Huguet F, Canal P, Laurent G, Pris J. Schlaifer D, et al. Among authors: pris j. Semin Hematol. 1994 Apr;31(2 Suppl 3):31. Semin Hematol. 1994. PMID: 8073306 No abstract available.

4

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.

Attal M, Canal P, Schlaifer D, Chatelut E, Dezeuze A, Huguet F, Payen C, Pris J, Laurent G. Attal M, et al. Among authors: pris j. J Clin Oncol. 1994 Jan;12(1):141-8. doi: 10.1200/JCO.1994.12.1.141. J Clin Oncol. 1994. PMID: 8270970 Clinical Trial.

5

Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.

Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J. Attal M, et al. Among authors: pris j. Blood. 1993 Aug 1;82(3):732-6. Blood. 1993. PMID: 8338943 Free article. Clinical Trial.

6

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

Attal M, Schlaifer D, Rubie H, Huguet F, Charlet JP, Bloom E, Lemozy J, Massip P, Pris J, Laurent G. Attal M, et al. Among authors: pris j. J Clin Oncol. 1991 May;9(5):865-70. doi: 10.1200/JCO.1991.9.5.865. J Clin Oncol. 1991. PMID: 2016630 Clinical Trial.

7

[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].

Rubie H, Attal M, Lemozy J, Massip P, Huguet F, Pris J, Robert A, Régnier C. Rubie H, et al. Among authors: pris j. Pathol Biol (Paris). 1988 Sep;36(7):912-4. Pathol Biol (Paris). 1988. PMID: 3059276 French.

8

Symptomatic osteonecrosis in recipients of nonautologous bone marrow transplants.

Sixou L, Lassoued S, Attal M, Dromer C, Leguennec P, Ludot I, Laroche M, Pris J, Fournié B. Sixou L, et al. Among authors: pris j. Rev Rhum Engl Ed. 1995 May;62(5):359-63. Rev Rhum Engl Ed. 1995. PMID: 7655869

9

Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study.

Reiffers J, Stoppa AM, Attal M, Michallet M, Marit G, Blaise D, Huguet F, Corront B, Cony-Makhoul P, Gastaut JA, Laurent G, Molina L, Broustet A, Maraninchi D, Pris J, Hollard D, Faberes C. Reiffers J, et al. Among authors: pris j. Leukemia. 1996 Dec;10(12):1874-82. Leukemia. 1996. PMID: 8946925 Clinical Trial.

10

[Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases].

Assoun J, Poey C, Attal M, Huguet F, De Haldat F, Giron J, Maquin P, Pris J, Railhac JJ. Assoun J, et al. Among authors: pris j. Ann Radiol (Paris). 1991;34(6-7):383-6, 389-92. Ann Radiol (Paris). 1991. PMID: 1822661 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters